Skip to content

Clinical Efficacy and Experimental Research on Zhang Yonghua's Prescription of Qinlian Wendan Decoction in Treating Insomnia with Phlegm-Heat Disturbing the Heart Based on the Theory of the Microbiota-Gut-Brain Axis

Clinical Efficacy and Experimental Research on Zhang Yonghua's Prescription of Qinlian Wendan Decoction in Treating Insomnia with Phlegm-Heat Disturbing the Heart Based on the Theory of the Microbiota-Gut-Brain Axis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000374
Enrollment
Unknown
Registered
2025-02-20
Start date
2024-12-02
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sleep disorder

Interventions

Traditional Chinese Medicine group:Take Qinlian Wendan Tang decoction, one packet at 2 PM and 8 PM daily, for a four-week course
Western medicine group:Take 1mg of Estazolam tablet every night before bedtime with a treatment course of 4 weeks
Healthy control group:None

Sponsors

Hangzhou Seventh People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: A. Meets the diagnostic criteria for insomnia disorder as defined by DSM-5; B. Adults aged between 18 and 65 years (inclusive of 18 and 65 years); C. Patients with a PSQI score of 8-15 (including 8 and 15) indicating mild to moderate insomnia; D. Voluntarily participates in this study and signs the informed consent form.

Exclusion criteria

Exclusion criteria: A. Individuals with systemic conditions such as pain fever cough or surgery that may contribute to insomnia; B. Patients with severe primary diseases of the cardiovascular pulmonary hepatic renal hematological or immune systems as well as psychiatric disorders; C. Those who have used hormones or immunosuppressants within the last 2 months taken SSRI/SNRIs or MAO inhibitors within the last month or used sedative-hypnotic drugs within the last 2 weeks which may affect the outcome measures; D. Patients with psychiatric disorders such as depression or severe anxiety who are at risk of suicide (PHQ-9 score > 9 or a score of 1 or higher on item 9); E. Women of childbearing age who may become pregnant are currently pregnant or are breastfeeding during the trial period; F. Individuals who are not currently using antibiotics have not used antibiotics within the 4 weeks prior to baseline have not taken over-the-counter probiotics for at least 2 weeks before baseline and are not taking any supplements; G. Exclusion of other organic diseases (e.g. cancer tuberculosis intestinal tuberculosis gastrointestinal disorders and diseases of other organ systems).

Design outcomes

Primary

MeasureTime frame
Traditional Chinese Medicine (TCM) Syndrome Score Scale;Pittsburgh Sleep Quality Index (PSQI);The abundance of gut microbiota;

Secondary

MeasureTime frame
Generalized Anxiety Disorder-7 (GAD-7);Self-Rating Depression Scale;Perceived Deficits Questionnaire-Depression;Polysomnography;Self-Rating Anxiety Scale;Patient Health Questionnaire-9 (PHQ-9);

Countries

china

Contacts

Public Contactliuwenjuan

The Seventh People's Hospital of Hangzhou City

juan_2001juan@163.com13805709525

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026